Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ALR Technologies SGALRTF +20.17% EV-to-EBIT is -18.91 as of Jul. 24, 2026. The stock has 4 warning signs investors should review. Among 465 Medical Devices & Instruments companies, ALR Technologies SG ranks worse than 215053.55% on this metric.
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
ALR Technologies SG's Enterprise Value for the quarter that ended in Dec. 2025 was $42.59 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ALR Technologies SG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALR Technologies SG EV-to-EBIT Related Terms
ALR Technologies SG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for ALR Technologies SG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, ALR Technologies SG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ALR Technologies SG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where ALR Technologies SG's EV-to-EBIT falls into.
ALR Technologies SG's current Enterprise Value is $43.90 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. ALR Technologies SG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $-2.32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ALR Technologies SG (ALRTF) has a EV-to-EBIT of -18.91 as of Jul. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on ALR Technologies SG and its competitors. According to the industry distribution chart, ALR Technologies SG ranks #999999 out of 465 companies in the Medical Devices & Instruments industry.
Is ALR Technologies SG's EV-to-EBIT too high?
ALR Technologies SG's current EV-to-EBIT is -18.91. Based on the distribution chart, ALR Technologies SG ranks #999999 out of 465 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does ALR Technologies SG's EV-to-EBIT compare to CODX and SINT?
According to the Medical Devices & Instruments industry distribution chart, ALR Technologies SG ranks #999999 out of 465 companies for EV-to-EBIT. This places ALR Technologies SG in the lower half of its industry. The industry median EV-to-EBIT is 18.19. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on ALR Technologies SG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ALR Technologies SG's current EV-to-EBIT is -18.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ALR Technologies SG stock overvalued right now?
ALR Technologies SG (ALRTF) has a current EV-to-EBIT of -18.91. The current EV-to-EBIT is -18.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For ALR Technologies SG (ALRTF), the current EV-to-EBIT is -18.91 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
ALR Technologies SG Ltd is a medical device company that focuses on commercializing its Health-e-Connect System. The company is a data management company that developed a comprehensive approach to diabetes care that includes an FDA-cleared and HIPAA-compliant Diabetes Solution product that can collect data from BGM and CGM; a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. Geographically, it operates in the United States and Singapore.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALRTF has been successfully added to your 
